OSR Holdings, Inc. Share Price
OSRHOSR Holdings, Inc. Stock Performance
Open $0.53 | Prev. Close $0.48 | Circuit Range N/A |
Day Range $0.52 - $0.84 | Year Range $0.38 - $1.79 | Volume 16,10,509 |
Average Traded $0.72 |
OSR Holdings, Inc. Share Price Chart
About OSR Holdings, Inc.
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
OSR Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Apr-26 | $0.53 | $0.70 | +0.00% |
30-Apr-26 | $0.53 | $0.70 | -5.64% |
28-Apr-26 | $0.69 | $0.74 | -1.46% |
27-Apr-26 | $0.72 | $0.76 | +9.57% |
24-Apr-26 | $0.59 | $0.69 | +16.36% |
23-Apr-26 | $0.59 | $0.59 | +2.60% |
22-Apr-26 | $0.57 | $0.58 | -1.87% |